Advertisement
IQV vs IRIX
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IQV is a StrongBuy and IRIX is a StrongBuy.
IQV | IRIX | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 79 | 51 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 65 Fair valued | 95 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 43 | 100 | |
PRICE GROWTH RATING 1..100 | 24 | 87 | |
P/E GROWTH RATING 1..100 | 18 | 1 | |
SEASONALITY SCORE 1..100 | 50 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
IQV's Valuation (65) in the Servicestothe Health Industry industry is in the same range as IRIX (95) in the Medical Specialties industry. This means that IQV’s stock grew similarly to IRIX’s over the last 12 months.
IQV's Profit vs Risk Rating (100) in the Servicestothe Health Industry industry is in the same range as IRIX (100) in the Medical Specialties industry. This means that IQV’s stock grew similarly to IRIX’s over the last 12 months.
IQV's SMR Rating (43) in the Servicestothe Health Industry industry is somewhat better than the same rating for IRIX (100) in the Medical Specialties industry. This means that IQV’s stock grew somewhat faster than IRIX’s over the last 12 months.
IQV's Price Growth Rating (24) in the Servicestothe Health Industry industry is somewhat better than the same rating for IRIX (87) in the Medical Specialties industry. This means that IQV’s stock grew somewhat faster than IRIX’s over the last 12 months.
IRIX's P/E Growth Rating (1) in the Medical Specialties industry is in the same range as IQV (18) in the Servicestothe Health Industry industry. This means that IRIX’s stock grew similarly to IQV’s over the last 12 months.
| IQV | IRIX | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 61% | 2 days ago 87% |
| Stochastic ODDS (%) | 2 days ago 60% | 2 days ago 73% |
| Momentum ODDS (%) | 2 days ago 72% | 2 days ago 83% |
| MACD ODDS (%) | 2 days ago 64% | 2 days ago 75% |
| TrendWeek ODDS (%) | 2 days ago 65% | 2 days ago 75% |
| TrendMonth ODDS (%) | 2 days ago 71% | 2 days ago 83% |
| Advances ODDS (%) | 11 days ago 63% | 15 days ago 76% |
| Declines ODDS (%) | 2 days ago 64% | 5 days ago 81% |
| BollingerBands ODDS (%) | 2 days ago 55% | 2 days ago 77% |
| Aroon ODDS (%) | 2 days ago 56% | 2 days ago 84% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
IQV’s FA Score shows that 2 FA rating(s) are green while IRIX’s FA Score has 1 green FA rating(s).
- IQV’s FA Score: 2 green, 3 red.
- IRIX’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
IQV’s TA Score shows that 4 TA indicator(s) are bullish while IRIX’s TA Score has 5 bullish TA indicator(s).
- IQV’s TA Score: 4 bullish, 4 bearish.
- IRIX’s TA Score: 5 bullish, 3 bearish.
Price Growth
IQV (@Medical Specialties) experienced а -5.20% price change this week, while IRIX (@Medical/Nursing Services) price change was +0.32% for the same time period.
The average weekly price growth across all stocks in the @Medical Specialties industry was -2.80%. For the same industry, the average monthly price growth was +3.90%, and the average quarterly price growth was +46.85%.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -2.19%. For the same industry, the average monthly price growth was -6.00%, and the average quarterly price growth was -2.76%.
Reported Earning Dates
IQV is expected to report earnings on Oct 27, 2026.
IRIX is expected to report earnings on Nov 17, 2026.
Industries' Descriptions
@Medical Specialties (-2.80% weekly)Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
@Medical/Nursing Services (-2.19% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
Advertisement
IQV and
Correlation & Price change
A.I.dvisor indicates that over the last year, IQV has been closely correlated with CRL. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if IQV jumps, then CRL could also see price increases.
IRIX and
Correlation & Price change
A.I.dvisor tells us that IRIX and NTRA have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IRIX and NTRA's prices will move in lockstep.
| Ticker / NAME | Correlation To IRIX | 1D Price Change % | ||
|---|---|---|---|---|
| IRIX | 100% | +0.32% | ||
| NTRA - IRIX | 30% Poorly correlated | -1.17% | ||
| NEO - IRIX | 27% Poorly correlated | -3.16% | ||
| IQV - IRIX | 27% Poorly correlated | -3.02% | ||
| MDXH - IRIX | 26% Poorly correlated | -1.44% | ||
| DRIO - IRIX | 26% Poorly correlated | -6.95% | ||
More | ||||